Trade Summary
3 weeks ago, Payne John Bernard, serving as Pres, CEO at Zivo Bioscience, Inc. (ZIVO), purchased 11,709 shares at $8.54 per share, for a total transaction value of $99,995.00. Following this transaction, Payne John Bernard now holds 19,618 shares of ZIVO.
This purchase represents a 148.00% increase in Payne John Bernard's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Monday, January 26, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, January 28, 2026, 2 days after the trade was made.
Zivo Bioscience, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.
